Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Lucid win PMEA Support Agency of the Year 2016

    November 24, 2016 | Behavioural science, Medical communication, behavioural change, medical education 

    - PMLiVE
    Last night the Lancaster London Hotel hosted the annual PMEA awards. These awards recognise and commend companies and programmes demonstrating excellence, best practice and innovation in improving patient outcomes on a local and global scale. 

    Lucid entered four categories and were shortlisted for them all! The company was therefore delighted to attend the awards last night and scoop two of the prizes, and receive a high commendation in the other two categories.    

    Winner: Support Agency of Year     – Lucid Group.     This new category recognises excellent work from companies in support sectors who have provided their pharmaceutical clients with outstanding assistance across their businesses.Judges’ comments: “Lucid demonstrated great strategy, innovative developments and effective motivation of their own team. They drive measurable improvement in patient outcomes and have a commitment to truly embedding behaviour change principles in their solutions.” 

    Winner: Excellence in Physicians / Healthcare Provider Support Programmes     – Psoriasis Expert Exchange FoRum (PEER)     This programme aims to change clinical behaviour on a global scale to improve standards of care in the management of psoriatic arthritis.Judges’ comments: “In taking a different approach, this work stands out from the many support programmes already out there. AbbVie and Lucid really understood behaviour change and showed how this understanding could be applied for high impact. We really liked the very clear link between strategy and tactics in the PEER programme, leading to excellent implementation.” 

    Highly Commended: Innovation     – Advance Outcomes®     Lucid’s innovative Advance Outcomes® approach employs a behaviour-change model for medical education to achieve improved, measurable healthcare and patient outcomes. 

    Highly Commended: Excellence in Healthcare Collaboration and Partnerships     – The Ulcerative Colitis Endoscopic Index of Severity Online Tool     

    Jan Steele (Lucid Co-Founder andCOO) commented: “Being recognised for our work at these awards makes me incredibly proud of the team we have built over the last decade. The judge’s comments were great in acknowledging the work we have done to bring behaviour changing approaches to our medical education.  And these awards also reflect strong partnerships with talented clients who understand the importance of driving clinically meaningful improvements in patient outcomes, rather than just focusing on brand metrics. The PEER programme is a great example of how we support both our clients and the patients they are aiming to help by driving up standards of care through a strategy that is underpinned by behaviour-change techniques.”  
    - PMLiVE 

    This content was provided by Lucid Group Communications Limited

    Company Details

    - PMLiVE

    Lucid Group Communications Limited

    Email
    Website

     Latest Content from  Lucid Group Communications Limited 

    Lucid Strategy Consulting: Empowering Next-Generation Solutions for Life Sciences

    Lucid Group announces the evolution of its consulting division, Lucid Strategy Consulting, setting a new standard for deep-domain, knowledge-led consulting solutions for life sciences. We have brought together two Lucid...

    My Lucid journey from PMW to Head of Medical

    Working in Medical Communications has never been about the nine to five. Fusing science and language in the service of both clients and patients, this is typically a fast paced...

    Listen, learn and lift off

    In April’s PME, Danny Buckland has been talking to industry leaders about launch excellence in the featured article, Listen, learn and lift off.Buckland points out that pandemic storms have changed the...

    Launch excellence

    In the April edition of PME, Cheryl Harrison Doyle, Global Asset Strategy Director at Lucid Group discusses the need to take a more considered, outcomes-led approach when launching new medicines...

    Meet The Lucid Group Talent Team

    Meet our talent team, they're here to help and transform your career.We have some exciting roles at all levels in account management and medical writing.If you choose to take your...

    Extraordinary lives: advancing change in rare diseases (Part 2)

    In support of Rare Disease Day, we’re excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so...

    Extraordinary lives: advancing change in rare diseases (Part 2)

    In support of Rare Disease Day, we're excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so...

    Extraordinary lives: advancing change in rare diseases (Part 1)

    Extraordinary lives: advancing change in rare diseases (Part 1)

    Rare Disease Day is all about raising awareness and generating change for the 300 million people worldwide living with a rare disease. The global rare disease community and its supporters come together on...

    My Journey into MedComms #LucidLife

    I began as a medical writer after almost a decade working in medical publishing as a production editor. Whilst working in publishing, I was exposed to lots of different writing...